RiverFront Investment Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
5,904
+524
| +10% | +$56.3K | 0.01% | 184 |
|
|
2025
Q1 | $543K | Buy |
5,380
+1,799
| +50% | +$181K | 0.01% | 184 |
|
|
2024
Q4 | $320K | Buy |
3,581
+561
| +19% | +$50.1K | 0.01% | 197 |
|
|
2024
Q3 | $253K | Buy |
3,020
+141
| +5% | +$11.8K | 0.01% | 190 |
|
|
2024
Q2 | $222K | Buy |
+2,879
| New | +$222K | 0.01% | 157 |
|
|
2022
Q2 | – | Sell |
-5,136
| Closed | -$227K | – | 99 |
|
|
2022
Q1 | $227K | Sell |
5,136
-145
| -3% | -$6.41K | 0.01% | 97 |
|
|
2021
Q4 | $224K | Sell |
5,281
-116,420
| -96% | -$4.94M | 0.01% | 93 |
|
|
2021
Q3 | $5.28M | Sell |
121,701
-128,341
| -51% | -$5.57M | 0.18% | 50 |
|
|
2021
Q2 | $10.7M | Sell |
250,042
-834
| -0.3% | -$35.7K | 0.22% | 52 |
|
|
2021
Q1 | $9.7M | Buy |
250,876
+8,582
| +4% | +$332K | 0.2% | 55 |
|
|
2020
Q4 | $8.71M | Buy |
+242,294
| New | +$8.71M | 0.19% | 57 |
|